Log in to your Inderes Free account to see all free content on this page.
Coloplast
886.8
DKK
-0.31 %
COLO B
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
4 following
-0.31%
+1.72%
-3.82%
+8.38%
+14.87%
+12.45%
-15.82%
+11.6%
+1,790.83%
investor.coloplast.com/investor-relations
Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Revenue
27.03B
EBIT %
27.08 %
P/E
39.48
Dividend yield-%
2.48 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
COLO B
Daily low / high price
884.2 / 895.2
DKK
Market cap
202.37B DKK
Turnover
137.85M DKK
Volume
155K
Financial calendar
General meeting
05.12.2024
Half year dividend
06.12.2024
Interim report
04.02.2025
Interim report
06.04.2025
Interim report
19.08.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Niels Peter Louis-Hansen | 20.7 % | 41.1 % |
Aage og Johanne Louis-Hansens Fond | 11.5 % | 15.2 % |
Benedicte Fund | 3.7 % | 5.4 % |
ShowingAll content types
Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy
Coloplast A/S - Notice of Annual General Meeting 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio